Afya (AFYA)
NASDAQ:AFYA
Want to see AFYA full AI Analyst Report?
AFYA Stock Chart & Stats
$15.00
$0.11(0.70%)
At close: 4:00 PM EST
$15.00
$0.11(0.70%)
Day’s Range― - ―
52-Week Range$13.00 - $19.90
Previous CloseN/A
Volume36.70K
Average Volume (3M)78.52K
Market Cap
$1.39B
Enterprise Value$9.00B
Total Cash (Recent Filing)$1.12B
Total Debt (Recent Filing)$3.12B
Price to Earnings (P/E)10.9
Beta0.63
Next Earnings
May 27, 2026EPS Estimate
0.58Next Dividend Ex-DateN/A
Dividend Yield<0.01%
Share Statistics
EPS (TTM)0.45
Shares Outstanding51,293,550
10 Day Avg. Volume78,346
30 Day Avg. Volume78,516
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)1.57
Price to Sales (P/S)2.11
P/FCF Ratio7.37
Enterprise Value/Market Cap6.46
Enterprise Value/Revenue2.42
Enterprise Value/Gross Profit3.76
Enterprise Value/Ebitda5.70
Forecast
1Y Price Target
$16.33Price Target Upside8.89% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
EPS Forecast (FY)9.37
Revenue Forecast (FY)$3.99B
Bulls Say, Bears Say
Bulls Say
Margin Improvement TrendModest margin expansion following recent trends suggests improving operational efficiency that can enhance profitability as revenue grows.
Organic Revenue Growth Across SegmentsBroad-based organic revenue growth across segments indicates diversified demand that can underpin more stable top-line performance.
Undergraduate Cash GenerationStrong cash generation from undergraduate programs supports the valuation and may sustain shareholder returns while investments continue.
Bears Say
AI Competition Undermining Subscription ModelWhitebook faces strong competition from AI-based medical apps that undercut subscription pricing, risking subscription revenue and user retention.
Non-core Investments Weighing On ReturnsRising investments in non-core businesses are likely to pressure shareholder returns by reallocating cash away from dividends or buybacks.
Slow Ramp Of Medical Practice SolutionsSlower-than-expected ramp of medical practice solutions limits revenue contribution and could delay anticipated earnings improvements.
Afya News
AFYA FAQ
What was Afya’s price range in the past 12 months?
Afya lowest stock price was $13.00 and its highest was $19.90 in the past 12 months.
What is Afya’s market cap?
Afya’s market cap is $1.39B.
When is Afya’s upcoming earnings report date?
Afya’s upcoming earnings report date is May 27, 2026 which is in 41 days.
How were Afya’s earnings last quarter?
Afya released its earnings results on Mar 13, 2026. The company reported $0.451 earnings per share for the quarter, beating the consensus estimate of $0.366 by $0.085.
Is Afya overvalued?
According to Wall Street analysts Afya’s price is currently Undervalued.
Does Afya pay dividends?
Afya pays a Notavailable dividend of $0.232 which represents an annual dividend yield of <0.01%. See more information on Afya dividends here
What is Afya’s EPS estimate?
Afya’s EPS estimate is 0.58.
How many shares outstanding does Afya have?
Afya has 51,293,550 shares outstanding.
What happened to Afya’s price movement after its last earnings report?
Afya reported an EPS of $0.451 in its last earnings report, beating expectations of $0.366. Following the earnings report the stock price went up 1.926%.
Which hedge fund is a major shareholder of Afya?
Currently, no hedge funds are holding shares in AFYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Afya Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$16.33 (8.89% Upside)
$16.33 (8.89% Upside)
Blogger Sentiment
Neutral
AFYA Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 125.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.20%
12-Months-Change
Fundamentals
Return on Equity
16.24%
Trailing 12-Months
Asset Growth
19.49%
Trailing 12-Months
Company Description
Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
AFYA Company Deck
AFYA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a strongly positive operational and financial performance for 2025: solid revenue growth (+12% YoY), record-ish margins and profitability metrics, robust cash generation, conservative leverage (0.8x net debt/EBITDA), and an explicit capital return program (dividends and buybacks). Management is pivoting to multi-year investments to integrate products, deepen physician engagement and scale B2B/B2P monetization, which moderates near-term margins and introduces execution and timing risk (e.g., rebuilding Residency Journey, softer MAUs, regulatory uncertainty around ENAMED/ProFMed). Overall, the highlights (growth, cash generation, low leverage, shareholder returns, clear strategy) substantially outweigh the lowlights (segment softness, engagement dip, guidance margin compression and regulatory questions).View all AFYA earnings summariesAFYA Stock 12 Month Forecast
Average Price Target
$16.33
▲(8.89% Upside)
Technical Analysis
Ownership Overview
― Insiders
10.76% Mutual Funds
14.71% Other Institutional Investors
74.00% Public Companies and
Individual Investors